To circumvent tumor immunosuppressive microenvironment, CAR‐NK cells containing CD28/CD137 signaling domains coupled with a truncated PD‐1 peptide were developed to target and kill MUC1‐positive cells which are abundant in metastatic solid tumors. Here, PDCD1 is linked to neoplasm.